Back to today’s briefing

Story perspectives

FDA Poised to Approve Non-Opioid Pain Breakthrough

1/14/2025

45 10

Summary

Story summary

The FDA is on the verge of approving suzetrigine, a groundbreaking non-opioid pain medication from Vertex Pharmaceuticals. Set for a month-end decision, this innovative treatment promises to tackle acute pain without the risk of addiction, potentially transforming the landscape of pain management for countless individuals.

1 of 1

Story summary

The FDA is on the verge of approving suzetrigine, a groundbreaking non-opioid pain medication from Vertex Pharmaceuticals. Set for a month-end decision, this innovative treatment promises to tackle acute pain without the risk of addiction, potentially transforming the landscape of pain management for countless individuals.